Glycoproteins: Emerging Markers of Inflammation
Cardiovascular events occur despite the control of conventional risk factors. Inflammation plays numerous roles in the pathogenesis of atherosclerotic cardiovascular
Discover the most recent news about our Company.
Cardiovascular events occur despite the control of conventional risk factors. Inflammation plays numerous roles in the pathogenesis of atherosclerotic cardiovascular
Metabolomic profiling involves identifying intermediary molecules and end-products of metabolism, encompassing lipids, lipoproteins, fatty acid variants, amino acids, and glycoprotein
On Monday, October 16, 2023, our CEO Núria Amigó participated in the event “Empowering the Future We Want” alongside Jose
Lipoproteins are much more than just vehicles for cholesterol in our body. Although lipid analysis has traditionally focused on measuring
Cardiovascular disease (CVD) claims the lives of over 4 million people in Europe every year. Dyslipidemia, a disorder characterized by
NMR metabolomics & AI in neonatal health Did you know that there are almost 3 million fetal and neonatal deaths every
La metabolòmica per RMN i IA en la salut neonatal Sabies que cada any hi ha gairebé 3 milions de
Biosfer Teslab assisteix a la International Manuel Rico NMR School Del 19 al 23 de juny, es va dur a
Biosfer Teslab asiste a la International Manuel Rico NMR School From June 19th to 23rd, the XV edition of the
Spring Highlights: international actions, conferences, and courses Biosfer Teslab a leading innovator in metabolomic based health applications and NMR services,
Swiss Biotech Day 24 y 25 de abril de 2023 Last 24th and 25th April, the Swiss Biotech Day took
Metabolomics: Personalised precision medicine is here With omics technologies we can obtain a more objective and complete view of the